About SDIX
SDIX is a company based in Newark (United States) founded in 1990. SDIX operates in a competitive market with competitors including KBI Biopharma, GenScript, EirGenix, Sino Biological and Aldevron, among others.
People of SDIX
8 people are tracked at SDIX (5 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Wei-Wu He | CEO | Leadership |
Ron Kaluzny | Vice President Of Sales And Marketing | Leadership |
Eric Li | Sr. Director, New Product Development And Technicall Sales | Leadership |
Dale Onisk | Vice President Of Polyclonal Development | Leadership |
Brenda Staehle | Senior Vice President & General Manager | Leadership |
Frank Vella | C.s.o. | Team |
Michael Hall | Project Manager Supervisor | Team |
Richard Harrington | Sales Account Manager IVD | Team |
Complete people profiles for SDIX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of SDIX
SDIX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, GenScript, EirGenix, Sino Biological and Aldevron, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kbibiopharma.com | 1996 | Durham, United States | $18.29M | 1,243 | Provider of protein formulation, process & cell line development, and cGMP services | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| eirgenix.com | 2012 | Taipei, Taiwan | $90.58M | – | Biologics development and manufacturing services are offered by EirGenix. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| aldevron.com | 1998 | Fargo, United States | – | 747 | Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications | |
| laurus.bio | 2005 | Bengaluru, India | $18.89M | 6,094 | Precision fermentation services for biopharma and food are provided. | |
| idt-biologika.com | 1921 | Dessau Rosslau, Germany | – | – | Vaccines and biologics are developed and manufactured by IDT Biologika. | |
| arrantabio.com | 2019 | Watertown, United States | $82M | – | Developer of therapeutics for microbiome based diseases | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | – | Monoclonal antibody technology and products are developed by Epitomics. |
Detailed competitors of SDIX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SDIX
The website of SDIX (sdix.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 61% vs previous month
Websites whose visitors overlap most with SDIX. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
proteogenix-antibody.com | proteogenix-antibody.com | 100% | – | – | – |
| studentadvantage.com | 64% | 1.8K | #8,748,901 | View details | |
lerner.udel.edu | lerner.udel.edu | 64% | – | – | – |
| vwr.com | 64% | 296.1K | #172,130 | View details | |
| stoneridgetechnology.com | 64% | 1.5K | #9,845,886 | View details |
Similar companies to SDIX
10 companies that operate in the same segment as SDIX (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SDIX
SDIX was founded in 1990.
SDIX is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
Wei-Wu He is the current CEO of SDIX.
SDIX was founded in 1990 and is based in Newark, United States, within the biotech sector. Operations focus on large-scale antibody production for research, in-vitro diagnostics, and therapeutic uses. Contract manufacturing services are provided for monoclonal and polyclonal antibodies under GMP standards, along with bioprocessing, cell banking, storage, and custom formulation of IVD reagents and controls.
SDIX's top competitors include KBI Biopharma, Sino Biological and GenScript.